T Rowe Price International Equity Index Fund (PIEQX)
17.12
+0.06
(+0.35%)
USD |
Mar 04 2025
Returns Chart
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| -- | -- | -- | -- |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -- | -- | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide long-term capital growth by trying to match the performance of the MSCI EAFE Index Net, a broadly diversified stock index designed to represent the performance of large- and mid-cap securities across developed markets, including Europe, Australasia and the Far East, except US and Canada. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Global ex US |
| Peer Group | International Large-Cap Core |
| Global Macro | Equity Global |
| US Macro | Developed International Markets Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | International Funds |
| Fund Owner Firm Name | T. Rowe Price |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
--
--
Peer Group Low
--
Peer Group High
1 Year
% Rank:
--
--
Peer Group Low
--
Peer Group High
3 Months
% Rank:
--
--
Peer Group Low
--
Peer Group High
3 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
6 Months
% Rank:
--
--
Peer Group Low
--
Peer Group High
5 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
YTD
% Rank:
--
--
Peer Group Low
--
Peer Group High
10 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of March 05, 2025.
Asset Allocation
As of December 31, 2024.
| Type | % Net |
|---|---|
| Cash | 1.54% |
| Stock | 96.83% |
| Bond | 1.33% |
| Convertible | 0.00% |
| Preferred | 0.33% |
| Other | -0.03% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| T Rowe Price Government Money Fund | 2.76% | 1.00 | 0.00% |
| ASML Holding NV | 1.72% | 725.74 | 1.17% |
| Novo Nordisk AS | 1.71% | 90.70 | 3.54% |
| SAP SE | 1.56% | 284.02 | 0.52% |
| Nestle SA | 1.32% | 99.71 | -0.97% |
| Toyota Motor Corp | 1.25% | 18.85 | 1.97% |
| AstraZeneca PLC | 1.24% | 149.10 | -2.65% |
| Roche Holding AG | 1.21% | 343.32 | -1.06% |
| Novartis AG | 1.18% | 112.04 | -0.71% |
| Shell PLC | 1.17% | 31.98 | -2.34% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | 0.09% |
| Administration Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | 0.00% |
| General Availability | |
| Available for Insurance Product | -- |
| Available for RRSP | -- |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 2500.00 None |
| Minimum Subsequent Investment | 100.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide long-term capital growth by trying to match the performance of the MSCI EAFE Index Net, a broadly diversified stock index designed to represent the performance of large- and mid-cap securities across developed markets, including Europe, Australasia and the Far East, except US and Canada. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Global ex US |
| Peer Group | International Large-Cap Core |
| Global Macro | Equity Global |
| US Macro | Developed International Markets Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | International Funds |
| Fund Owner Firm Name | T. Rowe Price |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM | -- |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| ROI (TTM) | -- |
| Return on Investment (TTM) | -- |
| Earning Yield | -- |
| LT Debt / Shareholders Equity | -- |
Growth Metrics
| EPS Growth (1Y) | 16.96% |
| EPS Growth (3Y) | 20.37% |
| EPS Growth (5Y) | 8.90% |
| Sales Growth (1Y) | 6.85% |
| Sales Growth (3Y) | 11.49% |
| Sales Growth (5Y) | 6.91% |
| Sales per Share Growth (1Y) | 8.92% |
| Sales per Share Growth (3Y) | 12.40% |
| Operating Cash Flow - Growth Ratge (3Y) | 9.56% |
As of December 31, 2024
Fund Details
| Key Dates | |
| Inception Date | 11/30/2000 |
| Last Annual Report Date | 10/31/2024 |
| Last Prospectus Date | 1/1/2025 |
| Share Classes | |
| TLIEX | Z |
| Attributes | |
| Index Fund |
|
| Inverse Fund | -- |
| Leveraged Fund | -- |
| Fund of Funds | No |
| Currency Hedged Fund | -- |
| Synthetic Replication Fund | No |
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:PIEQX", "name") |
| Broad Asset Class: =YCI("M:PIEQX", "broad_asset_class") |
| Broad Category: =YCI("M:PIEQX", "broad_category_group") |
| Prospectus Objective: =YCI("M:PIEQX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |